Lingle Abby, Baker Bethany, Williams Kristi, Lee Brian, Wright S Margaret, Yoder Alannah
Departments of Pharmacy (AL, BB, AY), General Academic Pediatrics (KW, MW), Health Services and Outcomes Research (BL), Children's Mercy Hospital, Kansas City, MO.
J Pediatr Pharmacol Ther. 2023;28(4):348-353. doi: 10.5863/1551-6776-28.4.348. Epub 2023 Aug 9.
The purpose of this study is to evaluate the effects of pharmacy integration into care transitions for children with medical complexity. These children are at a higher risk for medication errors and adverse effects because of their complex medication regimens. In addition, care transitions increase the risk for medication errors, especially during hospital-to-home transitions.
This was a retrospective chart review of patients enrolled in a complex care clinic who were discharged between September 1, 2021, and December 31, 2021, and who had received a discharge medication evaluation. Intervention categories were predetermined (medication reconciliation and clinical interventions) and documented. The primary outcome was to quantify and characterize the types of interventions made by the pharmacist. Descriptive statistics were used for data analysis. Continuous data were analyzed using Wilcoxon rank sum test, and correlation was measured using Spearman correlation values.
A total of 92 clinic encounters for 60 patients were included, with a median patient age of 7 years (IQR, 5-12.3), median length of stay of 3.2 days (IQR, 1.2-5.7), and a median number of 18 discharge medications (IQR, 14.8-25). A total of 283 interventions were made, consisting of 192 (68%) clinical interventions and 91 (32%) medication reconciliation interventions. In addition, 82 (89%) of the clinic encounters had at least one pharmacist intervention.
Pharmacist evaluation of a patient's discharge medication regimen clarifies and better optimizes the patient's medication regimen.
本研究旨在评估药学服务融入医疗复杂儿童护理过渡过程中的效果。由于用药方案复杂,这些儿童发生用药错误和不良反应的风险更高。此外,护理过渡会增加用药错误的风险,尤其是在从医院过渡到家庭的期间。
这是一项对在复杂护理诊所登记的患者进行的回顾性病历审查,这些患者于2021年9月1日至2021年12月31日出院,并接受了出院用药评估。干预类别预先确定(用药核对和临床干预)并记录在案。主要结果是量化并描述药剂师进行的干预类型。采用描述性统计进行数据分析。连续数据使用Wilcoxon秩和检验进行分析,相关性使用Spearman相关值进行测量。
共纳入60例患者的92次诊所诊疗记录,患者年龄中位数为7岁(四分位间距,5 - 12.3),住院时间中位数为3.2天(四分位间距,1.2 - 5.7),出院用药中位数为18种(四分位间距,14.8 - 25)。总共进行了283次干预,包括192次(68%)临床干预和91次(32%)用药核对干预。此外,82次(89%)诊所诊疗记录至少有一次药剂师干预。
药剂师对患者出院用药方案的评估能够明确并更好地优化患者的用药方案。